From: Prevalence of SARS-CoV-2 infection in neonates born to mothers or relatives with COVID-19
Results | Male | Female | Total | P. Value | |
---|---|---|---|---|---|
Parameters | Â | Â | Â | Â | |
 Age of all participants/days or years at the time of sampling | 41.8 ± 14.5 (1 day-91 years) | 42.9 ± 14.9 (1 day-93 years) | 42.5 ± 14.7 (1 day-93 years) | 0.404 Student T Test | |
 PCR results of SARS-CoV-2 for all participants | Positive | 3717 (27.7%) | 3034 (26.1%) | 6751 (27.0%) | 0.0036* Chi-Square Test |
Negative | 9692 (72.3%) | 8601 (73.9%) | 18,293 (73.0%) | ||
Total | 13,409 (53.5%) | 11,635 (46.5%) | 25,044 (100.0%) | Â | |
 Age of neonates/days at the time of sampling | 5.2 ± 7.8 (1–28 days) | 4.1 ± 5.7 (1–27 days) | 4.7 ± 6.9 (1–28 days) | 0.956 Mann-Whitney U Test | |
 Age groups of neonates (days) | 1–10 | 43 (87.8%) | 46 (93.9%) | 89 (90.8%) | 0.500 Chi-Square Test |
11–28 | 6 (12.2%) | 3 (6.1%) | 9 (9.2%) | ||
 PCR results of SARS-CoV-2 of all neonates | Positive | 6 (12.5%) | 0 (0.0%) | 6 (6.1%) | 0.013a Chi-Square Test |
Negative | 43 (87.5%) | 49 (100.0%) | 92 (93.9%) | ||
 Age of mothers/years at the time of sampling | – | – | 30.8 ± 5.1 (17–41 years) | – | |
 Age groups of mothers (years) | 15–20 | – | – | 4 (4.1%) | – |
21–25 | – | – | 12 (12.2%) | ||
26–30 | – | – | 32 (32.7%) | ||
31–35 | – | – | 30 (30.6%) | ||
35–40 | - | – | 18 (18.4%) | ||
> 40 | – | – | 2 (2.0%) |